Inflammation and Co-Infections in D²EFT

NCT04183738 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER_GOV

Sponsor class

Stopped In the context of COVID-19 pandemic.

Conditions

HIV-infection/Aids
Human Herpesvirus 4 Infections
Cytomegalovirus Infections
Human Herpesvirus 8 Infection
Human Papilloma Virus

Interventions

DRUG: NRTIs
DRUG: Darunavir
DRUG: Ritonavir
DRUG: Dolutegravir

Sponsor

Kirby Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]